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Relationship between ICR and 1-year major adverse cardiovascular events












Rate HR [95% CI] P-value
1.5mm 1494 22.0% (317) 1460 16.2% (228) 1.41 [1.19,1.67] 0.0001
1.75mm 1322 22.8% (290) 1632 16.2% (255) 1.47 [1.24,1.74] 0.0001
2.0mm 1103 23.4% (248) 1851 16.6% (297) 1.47 [1.24,1.74] 0.0001
2.25mm 853 22.7% (185) 2101 17.7% (360) 1.32 [1.10,1.57] 0.002
2.5mm 626 23.5% (142) 2328 18.0% (403) 1.38 [1.14,1.67] 0.001
2.75mm 427 25.7% (106) 2527 18.0% (439) 1.53 [1.24,1.89] 0.0001
3.0mm 298 24.3% (71) 2656 18.6% (474) 1.43 [1.11,1.83] 0.005
Value estimates are % (n) determined by Kaplan-Meier methods. CI denotes confidence interval; CR
denotes complete revascularization; HR denotes hazard ratio; ICR denotes incomplete coronary
revascularization; RVD denotes reference vessel diamter.
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Background: Microvascular obstruction (MVO), visualized with Cardiovascular Mag-
netic Resonance (CMR) imaging as a lack of Gadolinium-contrast wash-in, is a common
finding after a revascularized ST-elevation Myocardial Infarction (STEMI). Its presence
is associated with increased long-term morbidity and mortality. Using a porcine model of
coronary occlusion-reperfusion we correlated CMR-determined MVO with histopatho-
logical findings and compared this to CMR data performed in STEMI-patients.
Methods: In 8 Yorkshire swine, the circumflex coronary artery was occluded for 75
minutes by balloon catheter. After 7 days, CMR with cine imaging, T2-weighted
turbospinecho and Late Gadolinium Enhancement was performed to assess function,
infarct size, and the presence of intramyocardial hemorrhage (IMH) and/or MVO. CMR
findings were compared to histological findings after phosphotungstic acid-hematoxylin
and anti-CD31/Hematoxylin staining. CMR and histological findings were then compared
to CMR findings in 8 consecutive PCI-treated STEMI-patients.
Results: In the porcine model, the infarct core contained extensive necrosis, disruption of
microvasculature and extravasation of erythrocytes. The surrounding -Gadolinium-
enhanced- area contained granulation tissue, leukocyte infiltration and necrosis with
morphological intact microvessels containing microthrombi, but without extravasation of
erythrocytes. Areas with IMH (median size 1.92cm2,IQR 0.36-5.25cm2) and MVO
(median size 2.19cm2,IQR 0.40-4.58cm2) showed close anatomic correlation (Cronbach’s
0.91, r0.85, p0.03). In the 8 STEMI-patients, IMH (median size 8.11cm2,IQR
0.38-12.61cm2) and MVO (median size 5.05cm2,IQR 0-10.22cm2) area sizes showed
close anatomic correlation (0.99, r0.98, p0.001) as well.
Conclusions: IMH and MVO are frequently found in the core of the revascularized
STEMI and represent extensive microvascular damage with erythrocyte extravasation,
instead of microvascular obstruction. This has implications for the development of
adjunctive therapies after primary PCI.
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Background: In the Syntax study the Leaman weighing factor is used for the evaluation
of the left ventricular areas affected by the lesion. Taking the two main coronary
circulation systems the scoring system orders predefined points to the segments of the
coronary artery.
Methods: The coronary angiograms were analyzed retrospectively from the data of 19
patients deceased from ST-elevation myocardial infarction. The Leaman factor and the
result of an individualized coronary angiographic area at risk assessment called Holistic
Coronary Care (HCC) software were compared with the extent of infarction found by the
autopsy. With the consideration of the complementary distribution of the left anterior
descending artery and posterior descendent branch as well as the right and the left
coronary artery there were 3x412 circulation types registered in the HCC. The size of
the supplied area by the software (standard 17-segment model) was compared to the size
of the involved area according to the Leaman weighing factor.
Results: Multivariate regression analysis showed significant correlation between the
extension of the infarction detected by autopsy and the HCC segment number (r0.78,
p0.0002), while there was no significant correlation with the Leaman factor (r  0.46,
p  0.08).
Conclusions: With defining the individual circulation types with the HCC software it is
possible to determine the left ventricular segments related to the lesion with better
correlation than by Leaman weighing score.
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Background: Left ventricular (LV) dysfunction and multi-vessel disease (MVD) have
been associated with greater mortality after ST-segment elevation myocardial infarction.
We sought to evaluate their impact in patients treated with primary percutaneous coronary
intervention (PCI).
Methods: Patients from the HORIZONS-AMI trial treated with primary PCI in whom
baseline left ventricular ejection fraction (LVEF) was assessed by left ventriculography
were included in this study. Early and late (3-year) outcomes were examined in groups of
patients with reduced (40%) and preserved (40%) LVEF, further stratified by the
presence of MVD.
Results: 2,430 patients were included. Patients with reduced LVEF were older, were
more likely to be female, have a prior history of MI, PCI and congestive heart failure
(CHF), and present in CHF. Patients with reduced LVEF had greater 30-day (8.9% vs.
0.9%; HR [95%CI]  9.81 [5.23,18.42]; p0.0001) and 3-year mortality (17.1% vs.
3.7%; HR [95%CI]  5.03 [3.37,7.50]; p0.0001). Among patients with LVEF 30%
(n45), 30%-40% (n157), 40%-50% (n373), 50%-60% (n659) and 60%
(n1196), the 3-year mortality was 29.4%, 13.5%, 6.4%, 3.8% and 2.9% respectively (p
for trend0.0001). MVD was associated with greater mortality in patients with preserved
but not reduced LVEF. By multivariable analysis, LV dysfunction was the strongest
predictor of 30-day and 3-year mortality.
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Conclusions: In the contemporary era, the presence of baseline LV dysfunction in
patients undergoing primary PCI is a powerful predictor of early and late mortality,
regardless of the extent of coronary artery disease.
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Background: Previous studies have reported varying outcomes in pts with ACS and
non-obstructive CAD. Whether non-obstructive CAD confers the same prognosis in pts
with unstable angina (UA) compared to those with NSTEMI is unknown.
Methods: Of 6,921 pts with ACS undergoing an early invasive strategy in whom
quantitative angiography of the entire coronary artery tree was performed in the ACUITY
trial, those with a maximum stenosis of 50 % in all coronary arteries were defined as
non-obstructive CAD. Baseline features and outcomes through 1-year follow-up in such
pts treated without revascularization were examined according to whether they presented
with UA (CKMB or troponin ) or NSTEMI (CKMB or troponin 	).
Results: Non-obstructive CAD was present in 955 pts (14.4%) treated conservatively;
603 (63.1%) had UA whereas 352 (26.9%) had NSTEMI. Compared to pts with UA, pts
with NSTEMI were paradoxically less likely to require insulin; have hypertension or
hyperlipidemia; have had a prior MI or a previous PTCA; or present with ST-segment
deviation  1mm. Pts with NSTEMI were more likely to present at low to intermediate
TIMI risk. A similar percentage of pts with NSTEMI and UA received aspirin and/or a
thienopyridine on discharge. Pts with NSTEMI were more than twice as likely to die or
have an MI by 1 year than pts with UA, whereas unplanned revascularization was more
common in those with UA (Table).
Conclusions: Among ACS pts with non-obstructive CAD treated conservatively in the
ACUITY trial, despite having fewer cardiovascular risk factors at baseline, similar use of
anti-platelet therapies and requiring fewer revascularization procedures, pts with NSTEMI
were more than twice as likely as those with UA to die or have a MI by 1 year. Novel
approaches are required for pts with NSTEMI and non-obstructive CAD.
One-year clinical outcomes in patients with NSTEMI vs. UA
Outcome NSTEMI UA HR [95% CI] P-value
All-cause death 3.2 (11) 1.8 (10) 1.89 (0.80 - 4.54) 0.14
Myocardial infarction 1.5 (5) 0.2 (1) 8.33 (1.01 - 100.0) 0.02
Death or myocardial
infarction
4.7 (16) 2.0 (11) 2.50 (1.16 - 5.56) 0.01
Unplanned
revascularization
0.3 (1) 1.9 (11) 0.16 (0.02 - 1.20) 0.04
MACE 5.0 (17) 3.5 (20) 1.47 (0.77 - 2.78) 0.25
Value estimates are % (n) determined by Kaplan-Meier methods.
TCT-481
Comparison of newer generation drug-eluting stents with bare metal stents in
patients with acute ST-segment elevation myocardial infarction: A pooled
analysis of EXAMINATION and COMFORTABLE AMI trials
Manel Sabate1, Lorenz Räber2, Dik Heg3, Salvatore Brugaletta4,
Henning Kelbaek5, Angel Cequier6, Miodrag Ostojic7, Andres Iñiguez8,
David Tüller9, Antonio Serra10, Andreas Baumbach11, Patrick Serruys12,
Clemens von Birgelen13, Rosana Hernandez-Antolin14, Marco Roffi15,
Vicente Mainar16, Marco Valgimigli17, Peter Juni18, Stephan Windecker19
1University of Barcelona, Barcelona, Spain, 2Cardiology, Bern University
Hospital, Bern, Switzerland, 3Institute of Social and Preventive Medicine,
University of Bern, Bern Switzerland, Bern, Switzerland, 4Thorax institute,
Barcelona, Spain, 5Rigshospitalet Copenhagen, Copenhagen, Denmark, 6Hospital
of Bellvitge, Barcelona, Spain, 7University of Belgrade, School of Medicine,
Belgrade, Serbia, 8Hospital of Vigo, Vigo, Spain, 9Cardiology Department,
Triemlispital, Zurich, Switzerland, 10Hospital de Sant Pau y Santa Creu,
Barcelona, Spain, 11Bristol Heart Institute, Bristol, United Kingdom,
12Thoraxcenter-Erasmus University, Rotterdam, Netherlands, 13University of
Twente, Enschede, The Netherlands, 14Hospital Clinico San Carlos, Madrid, Spain,
15HOPITAUX UNIVERSITAIRES DE GENEVE (HUG), Geneva, Switzerland,
16Hospital Alicante, Alicante, Spain, 17University Hospital of Ferrara, Ferrara,
Italy, 18CTU Bern & ISPM, Bern, Switzerland, 19Bern University Hospital, Bern,
Switzerland
Background: Among patients with acute ST-segment elevation myocardial infarction-
(STEMI), early generation drug-eluting stents(DES) improve efficacy but not safety
compared with bare metal stents(BMS). Newer generation DES eluting everolimus(EES)
and biolimus A9(BES) have been shown to improve clinical outcomes compared with
early generation DES. However, it remains to be determined whether the benefits of
newer over early generation DES translate into improved safety compared with BMS
among appropriately powered population with STEMI.
Methods: Individual patient data of 2665 patients with STEMI enrolled into two large
scale randomized clinical trials comparing newer generation DES with BMS were pooled:
EXAMINATION randomly assigned 1504 patients to treatment with EES or BMS, and
COMFORTABLE AMI randomly assigned 1161 patients to treatment with BES or BMS.
Random effect models were used to assess differences in clinical outcomes between newer
generation DES and BMS for the pre-specified device-oriented composite of cardiac
death, target-vessel reinfarction and target-lesion revascularization and the patient-
oriented composite of death, reinfarction and any revascularization at one year.
Results: Newer generation DES substantially reduced the risk of the primary device-
oriented composite outcome compared with BMS at one year(RR 0.58, CI 95% 0.43 -
0.79, p 0.0004). Similarly, the risk of the primary patient-oriented composite outcome
was lower with newer generation DES than BMS(RR 0.78, 95% CI 0.63 to 0.96, p0.02).
Differences in favor of newer generation DES were driven by both, a lower risk of repeat
revascularization of the target lesion(RR 0.33, 95% CI 0.20–0.52, p0.0001) and a lower
risk of target-vessel reinfarction(RR 0.36, 95% CI 0.14-0.92, p0.03). Newer generation
DES reduced the risk of acute(RR 0.38, 95% CI 0.17-0.85, p0.02) and overall(within
one year) definite stent thrombosis(RR 0.35, 95% CI 0.16 – 0.75, p0.006) compared
with BMS.
Conclusions: Among patients with STEMI, newer generation DES improved safety and
efficacy compared with BMS throughout one year. It remains to be determined whether
these differences in favor of newer generation DES remain sustained during long-term
follow-up.
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Background: The purpose of this study was to determine safety and efficiency of
one-stage PCI of left main coronary artery (LMCA) and infarct-related left anterior
descending (LAD) or left circumflex (LCX) arteries in ST-elevation myocardial infarction
(STEMI). Even though STEMI guidelines recommend to limit the procedure to infarct-
related artery there are cases when it’s impossible to complete the PCI of the infarct-
related LAD or LCX without affecting LMCA. Appropriateness of one-phase PCI in such
cases needs to be investigated.
Methods: 281 PCI of LMCA were performed during the last 5 years. There were 57
stable and 224 ACS patients among them. LMCA lesion as the reason of ACS was in 19
patients, they were not included into the study. In other 205 cases LAD or LCX were
symptom-related accompanying significant LMCA lesions. The ACS subgroup (205
patients) contained 108 non-ST ACS patients and 97 STEMI patients. These 97 STEMI
patients with LMCA stenosis and infarct-related LAD or LCX were of major interest and
were followed up for 4 years.
Results: LAD was infarct-related in 65% of cases, LCX - in 35%. 7 patients were
admitted with cardiogenic shock. Concomitant RCA lesion was in 60% of cases. Most
procedures were performed using transradial approach (81%), IABP was used in 41% of
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